|
|
DSpace at RU >
Browsing by Author Wering, E.R. van
Showing results 1 to 13 of 13
| Full Text | Issue Date | Title | Author(s) | | 2010 | Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol. | Velden, V.H. van der; Sluijs-Geling, A. van der; Gibson, B.E.; Marvelde, J.G. Te; Hoogeveen, P.G., et al |
| 2010 | Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique. | Balgobind, B.V.; Hollink, I.H.; Reinhardt, D.; Wering, E.R. van; Graaf, S.S.N. de, et al |
| 2010 | EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia. | Balgobind, B.V.; Lugthart, S.; Hollink, I.H.; Arentsen-Peters, S.T.; Wering, E.R. van, et al |
| 2009 | Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004). | Veerman, A.J.P.; Kamps, W.A.; Berg, H. van den; Berg, E. van den; Bokkerink, J.P.M., et al |
| 2006 | Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group. | Loo, D.M.W.M. te; Kamps, W.A.; Berg, A. van den; Wering, E.R. van; Graaf, S.S.N. de |
| 2006 | Monitoring of inosine monophosphate dehydrogenase activity in mononuclear cells of children with acute lymphoblastic leukemia: enzymological and clinical aspects. | Brouwer, C.; Vermunt-de Koning, D.G.M.; Trueworthy, R.C.; Riet, P.G.J.H. ter; Duley, J.A., et al |
| 2005 | Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials. | Kardos, G.; Zwaan, C.M.; Kaspers, G.J.L.; Graaf, S.S.N. de; Bont, E.S. de, et al |
| 2005 | Role of 5'-nucleotidase in thiopurine metabolism: enzyme kinetic profile and association with thio-GMP levels in patients with acute lymphoblastic leukemia during 6-mercaptopurine treatment. | Brouwer, C.; Vogels-Mentink, T.M.; Keizer-Garritsen, J.J.; Trijbels, J.M.F.; Bökkerink, J.P.M., et al |
| 2005 | Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects. | Brouwer, C.; Abreu, R.A. de; Keizer-Garritsen, J.J.; Lambooy, L.H.J.; Ament, K., et al |
| 2004 | Three-colour flowcytometric analysis of mature and immature hematological malignancies : A guideline of the Dutch Foundation for Immunophyenotyping of Hematological Malignancies (SIHON) | Wering, E.R. van; Lochem, E.G. van; Leenders, M.; Sluijs-Gelling, A.J. van der; Wind, H., et al |
| 1996 | Het alveolaire rabdomyosarcoom met leukemische presentatie | Ensink, R.J.H.; Vaan, G.A.M. de; Wering, E.R. van |
| 1996 | Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia | Kaspers, G.J.L.; Veerman, A.J.P.; Popp-Snijders, C.; Lomecky, M.; Zantwijk, C.H. van, et al |
| 1996 | High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia: results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. | Veerman, A.J.P.; Hählen, K.; Kamps, W.A.; Leeuwen, E.F. van; Vaan, G.A.M. de, et al |
Showing results 1 to 13 of 13
|